RxDoctor Payments Data

Richard Leichter, DPM

Podiatrist · Red Bank, NJNPI 1871537746

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,034 of the $4,248 with a category attached, or 71.4%. 27 manufacturers reported payments, led by Stryker at 48.7% of the total. Reporting peaked in 2019 at $1,567 and has fallen 79.1% since, to $327 in 2025.

$4,248in general payments, 2019–2025

Across 86 payments — averaging $49.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Zimmer Biomet$268
  • Amgen$258
  • Convatec Inc.$233
  • Organogenesis Inc.$202
  • Nevro Corp.$183
  • plus $1K from 21 others

What the payments were for

  • Travel & lodging$1,21529%
  • Food & beverage$3,03471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,248 in reported general payments places this provider in the 80th percentile of 382 podiatrist providers in New Jersey.

See all podiatrist providers in New Jersey →

Medicare billing

Part B allowed, 2024
$214,214
Medicare patients
475
Services billed
3,653

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole44$640
Clobetasol Propionate11$342
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$242
Mupirocin22$120
Meloxicam27$70

Paid to pharmacies, not to this prescriber.

Other podiatrist in Red Bank

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →